- Home
- HOWL vs YSXT Comparison
HOWL vs YSXT Comparison
Compare HOWL & YSXT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | HOWL | YSXT |
|---|---|---|
| Founded | 2017 | 2011 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Automotive Aftermarket |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 64.5M | 29.5M |
| IPO Year | 2021 | 2024 |
Fundamental Metrics
Financial Performance| Metric | HOWL | YSXT |
|---|---|---|
| Price | $0.64 | $1.34 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $6.50 | N/A |
| AVG Volume (30 Days) | 891.1K | ★ 1.2M |
| Earning Date | 11-04-2025 | 02-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.18 |
| Revenue | N/A | ★ $71,452,736.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $7.46 |
| Revenue Growth | N/A | ★ 22.04 |
| 52 Week Low | $0.56 | $1.13 |
| 52 Week High | $2.38 | $9.96 |
Technical Indicators
Market Signals| Indicator | HOWL | YSXT |
|---|---|---|
| Relative Strength Index (RSI) | 33.54 | 39.31 |
| Support Level | $0.62 | $1.21 |
| Resistance Level | $0.67 | $1.35 |
| Average True Range (ATR) | 0.06 | 0.12 |
| MACD | 0.00 | 0.04 |
| Stochastic Oscillator | 32.75 | 70.00 |
Price Performance
Historical ComparisonAbout HOWL Werewolf Therapeutics Inc.
Werewolf Therapeutics Inc is a biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer. It is leveraging its proprietary PREDATOR platform to design conditionally activated molecules that stimulate both adaptive and innate immunity with the goal of addressing the limitations of conventional proinflammatory immune therapies. Its INDUKINE molecules are intended to remain inactive in peripheral tissue yet activate selectively in the tumor microenvironment or TME.
About YSXT YSX Tech. Co. Ltd Class A Ordinary Shares
YSX Tech Co Ltd provide business solutions to enterprise customers, mainly insurance companies and brokerages, in China. The company has three operating segments: Auto Insurance Aftermarket Value-added Services, Other Scenario-based Customized Services and Software Development and Information Technology Services. Key revenue is generated from Auto Insurance Aftermarket Value-added Services segment which include four types value added services: vehicle safety inspection and check services, vehicle driving risk screening services, designated driver and rescue services and vehicle maintenance and other value-added services.